Product Information
PHENTERMINE 37.5 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.0751 per EA under NDC 13107006199. Its NADAC has been published 546 times since Mar 11, 2015.
Strength
37.5 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107006199
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203068On Market Since
8/6/2014
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 37.5 MG TABLET has been published 546 times since Mar 11, 2015, and over the history we have for it it has declined 32.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0751 per EA |
|---|---|
| All-time high | $0.1262 (Jun 10, 2015) |
| All-time low | $0.0494 (Nov 20, 2024) |
| 52-week high | $0.0777 |
| 52-week low | $0.0751 |
| Median price | $0.0879 |
| Average price | $0.0909 |
| Largest weekly change | +51.9% (Jun 19, 2024) |
| Weeks tracked | 546 |
| Tracking since | Mar 11, 2015 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 37.5 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.0751 per EA (NDC 13107006199), effective Aug 20, 2025.
How has the price of PHENTERMINE 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 37.5 MG TABLET has declined 32.0%. It has been tracked across 546 weekly CMS publications since Mar 11, 2015.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 37.5 MG TABLET?
Since Mar 11, 2015, the NADAC for PHENTERMINE 37.5 MG TABLET has ranged from a low of $0.0494 (Nov 20, 2024) to a high of $0.1262 (Jun 10, 2015), with a median of $0.0879 per EA.
Are there cheaper alternatives to PHENTERMINE 37.5 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE 37.5 MG TABLET, is $0.0697 per EA — about 7% below PHENTERMINE 37.5 MG TABLET.
Who manufactures PHENTERMINE 37.5 MG TABLET?
PHENTERMINE 37.5 MG TABLET (NDC 13107006199) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification